Helicobacter pylori treatment results in Slovenia in the period 2013-2015 as a part of European Registry on Helicobacter pylori Management
Kategoria artykułu: Research Article
Data publikacji: 07 gru 2017
Zakres stron: 1 - 6
Otrzymano: 11 wrz 2017
Przyjęty: 05 lis 2017
DOI: https://doi.org/10.1515/raon-2017-0055
Słowa kluczowe
© 2018 Bojan Tepes, Marko Kastelic, Miroslav Vujasinovic, Polona Lampic, Maja Seruga, Natasa Brglez Jurecic, Olga P. Nyssen, Maria G. Donday, Colm O’Morain, Francis Megraud, Adrian G McNicholl, Javier P. Gisbert
This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Background
Patients and methods
Slovenia is a part of the European Registry on Helicobacter pylori Management from the beginning. In seven medical institutions data for
Results
Patients’ dropout was 11.4%. Eradication rate for 7 day triple therapy with proton pump inhibitor (PPI) + Clarithromycin (C) + Amoxicillin (A) was 88.7% PP and 72.0% mITT; for PPI + C + Metronidazole (M) 85.2% PP and 84.4% mITT. Second line 14 day therapy PPI + A + Levofloxacin had 92.3% eradication rate PP and 87.1% mITT. Ten to fourteen day Bismuth quadruple therapy was the therapy in difficult to treat patients. At the end all patients that adhered to prescribed regimens were cured of their
Conclusions
High dropout rate deserves further analysis. Slovenia is still a country with < 15%